{{'2020-12-29T11:12:38Z' | dateFormatFilter}}
Novo Nordisk files for EU regulatory approval of once-weekly semaglutide 2.0 mg for the treatment of type 2 diabetes
Read more
{{'2020-12-18T07:10:38Z' | dateFormatFilter}}
Novo Nordisk files for EU regulatory approval of once-weekly semaglutide 2.4 mg for weight management
Read more
{{'2020-12-16T13:08:15Z' | dateFormatFilter}}
Novo Nordisk to enter phase 3 development in Alzheimer’s disease with oral semaglutide
Read more
Here are our current job openings. If there is not a job you are looking for, you are welcome to create a job agent or a candidate profile.
Investors
Share price
{{priceData.date}} {{priceData.time}}